Loading clinical trials...
Loading clinical trials...
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Conditions
Interventions
AGN-199201 ophthalmic solution
AGN-190584 ophthalmic solution
+2 more
Locations
25
United States
Retina Institute of California Medical Group
Arcadia, California, United States
Sall Research Medical Center
Artesia, California, United States
WCCT Global, LLC
Cypress, California, United States
Specialty Eye Care Medical Center
Glendale, California, United States
Lugene Eye Institute
Glendale, California, United States
The Eye Research Foundation
Newport Beach, California, United States
Start Date
May 26, 2016
Primary Completion Date
October 31, 2017
Completion Date
October 31, 2017
Last Updated
December 22, 2020
NCT06060041
NCT03135327
NCT07051720
NCT06948357
NCT06869044
NCT04465409
Lead Sponsor
Allergan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions